Brimonidine Tartrate; Timolol Maleate Patent Expiration
Brimonidine Tartrate; Timolol Maleate is used for lowering elevated intraocular pressure in patients with glaucoma or ocular hypertension. It was first introduced by Abbvie Inc
Brimonidine Tartrate; Timolol Maleate Patents
Given below is the list of patents protecting Brimonidine Tartrate; Timolol Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Combigan | US7323463 | Combination of brimonidine and timolol for topical ophthalmic use |
Jan 19, 2023
(Expired) | Abbvie |
| Combigan | US7030149 | Combination of brimonidine timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US7320976 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US7642258 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US8133890 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US8354409 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US8748425 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9474751 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9770453 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9907801 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9907802 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
Brimonidine Tartrate; Timolol Maleate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List